Cargando…
A novel IgG Fc by computer-aided design enhances heavy-chain heterodimerization in bi- or trispecific antibodies
The classical `knob-into-holes' (KIH) strategy (knob(T366Y)/hole (Y407T)) has successfully enhanced the heterodimerization of a bispecific antibody (BsAb) resulting in heterodimer formation up to 92% of protein A (ProA)-purified protein pool. However, it does not show high efficiency for every...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413979/ https://www.ncbi.nlm.nih.gov/pubmed/36042698 http://dx.doi.org/10.1093/abt/tbac019 |
_version_ | 1784775882543464448 |
---|---|
author | Wang, Bo Lin, Jun Hoag, Matthew R Wright, Meredith Ma, Mingjun Cai, Wenyan Gallolu Kankanamalage, Sachith Liu, Yue |
author_facet | Wang, Bo Lin, Jun Hoag, Matthew R Wright, Meredith Ma, Mingjun Cai, Wenyan Gallolu Kankanamalage, Sachith Liu, Yue |
author_sort | Wang, Bo |
collection | PubMed |
description | The classical `knob-into-holes' (KIH) strategy (knob(T366Y)/hole (Y407T)) has successfully enhanced the heterodimerization of a bispecific antibody (BsAb) resulting in heterodimer formation up to 92% of protein A (ProA)-purified protein pool. However, it does not show high efficiency for every BsAb. KIH was initially applied to a CD20/CD3 BsAb. After in silico modeling, two additional new mutations, S354Y in knob-heavy chain (HC) and Q347E in hole-HC, together with KIH named `ETYY', were introduced in the Fc. The CD20/CD3 BsAb hybrid only represented ~ 50% of the ProA-purified protein pool when KIH was applied. With ETYY, the percentage of CD20/CD3 hybrid increased to 93.8%. CD20/CD3-v4b (containing ETYY) retains the original activity of the BsAb at both Fab and Fc regions, and also shows good developability. These results indicate that the computer-aided novel ETYY design has the potential to improve the development of next-generation BsAbs with higher yields and simpler purification. |
format | Online Article Text |
id | pubmed-9413979 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-94139792022-08-29 A novel IgG Fc by computer-aided design enhances heavy-chain heterodimerization in bi- or trispecific antibodies Wang, Bo Lin, Jun Hoag, Matthew R Wright, Meredith Ma, Mingjun Cai, Wenyan Gallolu Kankanamalage, Sachith Liu, Yue Antib Ther Original research article The classical `knob-into-holes' (KIH) strategy (knob(T366Y)/hole (Y407T)) has successfully enhanced the heterodimerization of a bispecific antibody (BsAb) resulting in heterodimer formation up to 92% of protein A (ProA)-purified protein pool. However, it does not show high efficiency for every BsAb. KIH was initially applied to a CD20/CD3 BsAb. After in silico modeling, two additional new mutations, S354Y in knob-heavy chain (HC) and Q347E in hole-HC, together with KIH named `ETYY', were introduced in the Fc. The CD20/CD3 BsAb hybrid only represented ~ 50% of the ProA-purified protein pool when KIH was applied. With ETYY, the percentage of CD20/CD3 hybrid increased to 93.8%. CD20/CD3-v4b (containing ETYY) retains the original activity of the BsAb at both Fab and Fc regions, and also shows good developability. These results indicate that the computer-aided novel ETYY design has the potential to improve the development of next-generation BsAbs with higher yields and simpler purification. Oxford University Press 2022-08-01 /pmc/articles/PMC9413979/ /pubmed/36042698 http://dx.doi.org/10.1093/abt/tbac019 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of Antibody Therapeutics. All rights reserved. For Permissions, please email: journals.permissions@oup.com https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Original research article Wang, Bo Lin, Jun Hoag, Matthew R Wright, Meredith Ma, Mingjun Cai, Wenyan Gallolu Kankanamalage, Sachith Liu, Yue A novel IgG Fc by computer-aided design enhances heavy-chain heterodimerization in bi- or trispecific antibodies |
title | A novel IgG Fc by computer-aided design enhances heavy-chain heterodimerization in bi- or trispecific antibodies |
title_full | A novel IgG Fc by computer-aided design enhances heavy-chain heterodimerization in bi- or trispecific antibodies |
title_fullStr | A novel IgG Fc by computer-aided design enhances heavy-chain heterodimerization in bi- or trispecific antibodies |
title_full_unstemmed | A novel IgG Fc by computer-aided design enhances heavy-chain heterodimerization in bi- or trispecific antibodies |
title_short | A novel IgG Fc by computer-aided design enhances heavy-chain heterodimerization in bi- or trispecific antibodies |
title_sort | novel igg fc by computer-aided design enhances heavy-chain heterodimerization in bi- or trispecific antibodies |
topic | Original research article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413979/ https://www.ncbi.nlm.nih.gov/pubmed/36042698 http://dx.doi.org/10.1093/abt/tbac019 |
work_keys_str_mv | AT wangbo anoveliggfcbycomputeraideddesignenhancesheavychainheterodimerizationinbiortrispecificantibodies AT linjun anoveliggfcbycomputeraideddesignenhancesheavychainheterodimerizationinbiortrispecificantibodies AT hoagmatthewr anoveliggfcbycomputeraideddesignenhancesheavychainheterodimerizationinbiortrispecificantibodies AT wrightmeredith anoveliggfcbycomputeraideddesignenhancesheavychainheterodimerizationinbiortrispecificantibodies AT mamingjun anoveliggfcbycomputeraideddesignenhancesheavychainheterodimerizationinbiortrispecificantibodies AT caiwenyan anoveliggfcbycomputeraideddesignenhancesheavychainheterodimerizationinbiortrispecificantibodies AT gallolukankanamalagesachith anoveliggfcbycomputeraideddesignenhancesheavychainheterodimerizationinbiortrispecificantibodies AT liuyue anoveliggfcbycomputeraideddesignenhancesheavychainheterodimerizationinbiortrispecificantibodies AT wangbo noveliggfcbycomputeraideddesignenhancesheavychainheterodimerizationinbiortrispecificantibodies AT linjun noveliggfcbycomputeraideddesignenhancesheavychainheterodimerizationinbiortrispecificantibodies AT hoagmatthewr noveliggfcbycomputeraideddesignenhancesheavychainheterodimerizationinbiortrispecificantibodies AT wrightmeredith noveliggfcbycomputeraideddesignenhancesheavychainheterodimerizationinbiortrispecificantibodies AT mamingjun noveliggfcbycomputeraideddesignenhancesheavychainheterodimerizationinbiortrispecificantibodies AT caiwenyan noveliggfcbycomputeraideddesignenhancesheavychainheterodimerizationinbiortrispecificantibodies AT gallolukankanamalagesachith noveliggfcbycomputeraideddesignenhancesheavychainheterodimerizationinbiortrispecificantibodies AT liuyue noveliggfcbycomputeraideddesignenhancesheavychainheterodimerizationinbiortrispecificantibodies |